ORIC: Oric Pharmaceuticals, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 6 sales totaling $465K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-20 | Piscitelli Dominic | CFO | $189K | yes |
| 2026-10-01 | Heyman Richard A. | Director | $45K | yes |
| 2026-10-01 | Heyman Richard A. | Director | $41K | yes |
| 2026-09-28 | Piscitelli Dominic | CFO | $181K | yes |
| 2026-09-24 | Piscitelli Dominic | CFO | $1K | yes |
| 2026-09-24 | Piscitelli Dominic | CFO | $7K | yes |
Institutional ownership (Q2 2026)
180 institutions reported holding $1.26B of Oric Pharmaceuticals, Inc. on Form 13F (182 the quarter before). 28 opened a new position and 30 sold out. Shares held by institutions: +3%.
| Largest holders | Shares | Value |
|---|---|---|
| Nextech Invest Ltd. | 7,162,637 | $77.57M |
| BlackRock, Inc. | 6,823,973 | $73.90M |
| EcoR1 Capital, LLC | 6,728,116 | $72.87M |
| VIKING GLOBAL INVESTORS LP | 5,126,762 | $55.52M |
| STATE STREET CORP | 4,894,000 | $53.00M |
| SR One Capital Management, LP | 4,615,384 | $49.98M |
| Venrock Adviser, LLC | 4,319,765 | $46.78M |
| NEA Management Company, LLC | 4,118,621 | $44.60M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,951,169 | $42.79M |
| AIHC Capital Management Ltd | 3,828,460 | $41.46M |
Clinical trial readouts
1 Phase 2 or 3 trials by Oric Pharmaceuticals, Inc. with a primary completion date in the last 90 days or the next 12 months and no results posted yet, from ClinicalTrials.gov. (est.) = company estimate.
| Primary completion | Drug | Condition | Phase | Patients | Status | Trial |
|---|---|---|---|---|---|---|
| 2026-09 (est.) | ORIC-114 | Solid Tumors | Phase 1/2 | 350 | Recruiting | NCT05315700 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.